Artykuły w czasopismach na temat „Anti-Saccharomyces cerevisiae antibody”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Anti-Saccharomyces cerevisiae antibody”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Fedrigo, Aiessa, Thelma L. Skare, André Luiz Bortoluzzi i Renato Nisihara. "ASCA (Anti-Saccharomyces cerevisiae Antibody) in Patients With Scleroderma". JCR: Journal of Clinical Rheumatology 25, nr 1 (styczeń 2019): 24–27. http://dx.doi.org/10.1097/rhu.0000000000000759.
Pełny tekst źródłaOshitani, Nobuhide. "Anti-Saccharomyces Cerevisiae Antibody and 5-aminosalicylic Acid Treatment". American Journal of Gastroenterology 99, nr 5 (maj 2004): 955. http://dx.doi.org/10.1111/j.1572-0241.2004.40044.x.
Pełny tekst źródłaTeml, Alexander, i Walter Reinisch. "Anti-Saccharomyces Cerevisiae Antibody and 5-aminosalicylic Acid Treatment: Response". American Journal of Gastroenterology 99, nr 5 (maj 2004): 956. http://dx.doi.org/10.1111/j.1572-0241.2004.40193.x.
Pełny tekst źródłaOshitani, N., F. Hato, Y. Jinno, Y. Sawa, S. Nakamura, T. Matsumoto, S. Seki, S. Kitagawa i T. Arakawa. "IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatory bowel disease". European Journal of Clinical Investigation 31, nr 3 (marzec 2001): 221–25. http://dx.doi.org/10.1046/j.1365-2362.2001.00798.x.
Pełny tekst źródłaFilik, Levent, i Ibrahim Biyikoglu. "Differentiation of Behcet’s disease from inflammatory bowel diseases: Anti-saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody". World Journal of Gastroenterology 14, nr 47 (2008): 7271. http://dx.doi.org/10.3748/wjg.14.7271.
Pełny tekst źródłaTandio Saputro, Shania Safera, Khayu Wahyunita, Astutiati Nurhasanah, Yudhi Nugraha, Irvan Faizal, Sabar Pambudi i Andri Pramesyanti Pramono. "Expression of modified enhanced green fluorescent polyarginine protein in Saccharomyces cerevisiae INVSc1". F1000Research 12 (3.01.2023): 1. http://dx.doi.org/10.12688/f1000research.123181.1.
Pełny tekst źródłaVermeire, Severine, Sofie Joossens, Marc Peeters, Fred Monsuur, Godelieve Marien, Xavier Bossuyt, Peter Groenen, Robert Vlietinck i Paul Rutgeerts. "Comparative study of ASCA (Anti–Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease". Gastroenterology 120, nr 4 (marzec 2001): 827–33. http://dx.doi.org/10.1053/gast.2001.22546.
Pełny tekst źródłaMakharia, Govind K., Vikas Sachdev, Rajiva Gupta, Suman Lal i R. M. Pandey. "Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis". Digestive Diseases and Sciences 52, nr 1 (8.12.2006): 33–39. http://dx.doi.org/10.1007/s10620-006-9527-0.
Pełny tekst źródłaChoi, Chang Hwan, Tae Il Kim, Byung Chang Kim, Sung Jae Shin, Sang Kil Lee, Won Ho Kim i Hyon Suk Kim. "Anti-Saccharomyces cerevisiae Antibody in Intestinal Behçetʼs Disease Patients: Relation to Clinical Course". Diseases of the Colon & Rectum 49, nr 12 (grudzień 2006): 1849–59. http://dx.doi.org/10.1007/s10350-006-0706-z.
Pełny tekst źródłaBelazi, Maria, Alexandra Fleva, Drakoulis Drakoulakos i Despina Panayiotidou. "Comparison of salivary IgA and systemic IgA and IgG antibodies to Saccharomyces cerevisiae in HIV-infected subjects". International Journal of STD & AIDS 14, nr 7 (1.07.2003): 458–62. http://dx.doi.org/10.1258/095646203322025759.
Pełny tekst źródłaGriffiths, Anne M., i Mary Zachos. "Antineutrophil Cytoplasmic Antibodies and Anti-Saccharomyces cerevisiae Antibody: Clinical Tools or Clues for Research?" Journal of Pediatric Gastroenterology and Nutrition 30, nr 1 (styczeń 2000): 1. http://dx.doi.org/10.1097/00005176-200001000-00006.
Pełny tekst źródłaStandaert–Vitse, Annie, Thierry Jouault, Peggy Vandewalle, Céline Mille, Mimouna Seddik, Boualem Sendid, Jean–Maurice Mallet, Jean–Frédéric Colombel i Daniel Poulain. "Candida albicans Is an Immunogen for Anti–Saccharomyces cerevisiae Antibody Markers of Crohn’s Disease". Gastroenterology 130, nr 6 (maj 2006): 1764–75. http://dx.doi.org/10.1053/j.gastro.2006.02.009.
Pełny tekst źródłaVermeulen, N., S. Vermeire, P. Rutgeerts i X. Bossuyt. "Likelihood ratio for Crohnʼs disease as a function of Anti-Saccharomyces cerevisiae antibody concentration". Inflammatory Bowel Diseases 16, nr 1 (styczeń 2010): 5–6. http://dx.doi.org/10.1002/ibd.20905.
Pełny tekst źródłaAshorn, Sara, Hanna Raukola, Tuuli Välineva, Merja Ashorn, Bo Wei, Jonathan Braun, Immo Rantala i in. "Elevated Serum Anti-Saccharomyces cerevisiae, Anti-I2 and Anti-OmpW Antibody Levels in Patients with Suspicion of Celiac Disease". Journal of Clinical Immunology 28, nr 5 (22.05.2008): 486–94. http://dx.doi.org/10.1007/s10875-008-9200-9.
Pełny tekst źródłaGorgel, Ahmet, Cem Cankaya i Mehmet Tecellioglu. "Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report". Endocrine, Metabolic & Immune Disorders - Drug Targets 19, nr 1 (3.01.2019): 90–94. http://dx.doi.org/10.2174/1871530318666180817143536.
Pełny tekst źródłaKansal, Shivani, Anthony G. Catto-Smith, Karen Boniface, Sarah Thomas, Donald J. Cameron, Mark Oliver, George Alex, Carl D. Kirkwood i Josef Wagner. "Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease". Journal of Pediatric Gastroenterology and Nutrition 69, nr 6 (grudzień 2019): 696–703. http://dx.doi.org/10.1097/mpg.0000000000002461.
Pełny tekst źródłaKirschner, Barbara S., Barbara S. Reid, Ranjana Gokhale i John Hart. "Chronic granulomatous disease (CGD) — another cause of anti-saccharomyces cerevisiae antibody (ASCA) positivty in children". Gastroenterology 118, nr 4 (kwiecień 2000): A104. http://dx.doi.org/10.1016/s0016-5085(00)82495-6.
Pełny tekst źródłaMusleh, Mustafa, Drew Triplett i Salma Akram. "Sa1186 Prognostic Significance of Anti-Saccharomyces Cerevisiae Antibody (ASCA) in Southwestern Ohio Veteran IBD Population". Gastroenterology 148, nr 4 (kwiecień 2015): S—251. http://dx.doi.org/10.1016/s0016-5085(15)30826-x.
Pełny tekst źródłaNeff, M. W., i D. J. Burke. "Random segregation of chromatids at mitosis in Saccharomyces cerevisiae." Genetics 127, nr 3 (1.03.1991): 463–73. http://dx.doi.org/10.1093/genetics/127.3.463.
Pełny tekst źródłaHu, Chaojun, Chuiwen Deng, Shulan Zhang, Guang Song, Lijun Li, Xi Li, Li Wang, Fengchun Zhang i Yongzhe Li. "Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis". Clinical and Experimental Medicine 13, nr 4 (15.09.2012): 245–50. http://dx.doi.org/10.1007/s10238-012-0207-4.
Pełny tekst źródłaGriffiths, Anne M., Mary Zachos, Philip M. Sherman i Hans Büller. "Antineutrophil Cytoplasmic Antibodies and Anti‐Saccharomyces cerevisiae Antibody: Clinical Tools or Clues for Research?" Journal of Pediatric Gastroenterology and Nutrition 30, nr 1 (styczeń 2000): 1. http://dx.doi.org/10.1002/j.1536-4801.2000.tb02648.x.
Pełny tekst źródłaForcione, D. G. "Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease". Gut 53, nr 8 (1.08.2004): 1117–22. http://dx.doi.org/10.1136/gut.2003.030734.
Pełny tekst źródłaKim, You Sun, Young-Ho Kim, Byong Duk Ye, Dong Won Park, Ji Won Kim i Dong Soo Han. "Mannose-binding lectin deficiency is not associated with Anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients". Clinica Chimica Acta 429 (luty 2014): 206–11. http://dx.doi.org/10.1016/j.cca.2013.12.019.
Pełny tekst źródłaBrockerhoff, S. E., i T. N. Davis. "Calmodulin concentrates at regions of cell growth in Saccharomyces cerevisiae." Journal of Cell Biology 118, nr 3 (1.08.1992): 619–29. http://dx.doi.org/10.1083/jcb.118.3.619.
Pełny tekst źródłaTodorov, I. T., R. Pepperkok, R. N. Philipova, S. E. Kearsey, W. Ansorge i D. Werner. "A human nuclear protein with sequence homology to a family of early S phase proteins is required for entry into S phase and for cell division". Journal of Cell Science 107, nr 1 (1.01.1994): 253–65. http://dx.doi.org/10.1242/jcs.107.1.253.
Pełny tekst źródłaFerreira, Sofia, Ana F. Raimundo, Inês Farrim i Regina Menezes. "Ablation of Kex2 activity enhances proIAPP proteotoxicity in yeast". Journal Biomedical and Biopharmaceutical Research 19, nr 2 (2022): 337–54. http://dx.doi.org/10.19277/bbr.19.2.301.
Pełny tekst źródłaKim, You Sun, Beom Jin Kim, Young-Ho Kim, Won Ho Kim, Joo Sung Kim, Young-Sook Park, Suk-Kyun Yang i in. "T1284 Anti-Saccharomyces Cerevisiae Antibody (ASCA) is a Useful Diagnostic Tool to Differentiate Crohn's Disease From Intestinal Tuberculosis". Gastroenterology 138, nr 5 (maj 2010): S—528. http://dx.doi.org/10.1016/s0016-5085(10)62438-9.
Pełny tekst źródłaKim, Y. S., Y. H. Kim, B. D. Ye, J. W. Kim i D. S. Han. "P195 Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients". Journal of Crohn's and Colitis 7 (luty 2013): S87. http://dx.doi.org/10.1016/s1873-9946(13)60217-2.
Pełny tekst źródłaZhou, Guangxi, Yang Song, Wenjing Yang, Yanmin Guo, Leilei Fang, Yamei Chen i Zhanju Liu. "ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?" Digestive Diseases 34, nr 1-2 (2016): 90–97. http://dx.doi.org/10.1159/000442934.
Pełny tekst źródłaBenmerah, A., J. Gagnon, B. Bègue, B. Mégarbané, A. Dautry-Varsat i N. Cerf-Bensussan. "The tyrosine kinase substrate eps15 is constitutively associated with the plasma membrane adaptor AP-2." Journal of Cell Biology 131, nr 6 (15.12.1995): 1831–38. http://dx.doi.org/10.1083/jcb.131.6.1831.
Pełny tekst źródłaSherwood, Roy A. "Faecal markers of gastrointestinal inflammation". Journal of Clinical Pathology 65, nr 11 (19.07.2012): 981–85. http://dx.doi.org/10.1136/jclinpath-2012-200901.
Pełny tekst źródłaSmith, Ben R. K., Ian D. R. Arnott, Hazel E. Drummond, Elaine R. Nimmo i Jack Satsangi. "Disease Location, Anti-Saccharomyces cerevisiae Antibody, and NOD2/CARD15 Genotype Influence the Progression of Disease Behavior in Crohn’s Disease". Inflammatory Bowel Diseases 10, nr 5 (wrzesień 2004): 521–28. http://dx.doi.org/10.1097/00054725-200409000-00005.
Pełny tekst źródłaCao, Liang, Che-man Chan, Cindy Lee, Samson Sai-yin Wong i Kwok-yung Yuen. "MP1 Encodes an Abundant and Highly Antigenic Cell Wall Mannoprotein in the Pathogenic Fungus Penicillium marneffei". Infection and Immunity 66, nr 3 (1.03.1998): 966–73. http://dx.doi.org/10.1128/iai.66.3.966-973.1998.
Pełny tekst źródłaYorulmaz, Elif, Gupse Adalı, Hatice Yorulmaz, Güralp Taşan, Seval Gürses, Mehmet Ramazan Ayaş i İlyas Tuncer. "The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease". Middle East Journal of Digestive Diseases 14, nr 3 (30.07.2022): 294–303. http://dx.doi.org/10.34172/mejdd.2022.286.
Pełny tekst źródłaLu, C. F., R. C. Montijn, J. L. Brown, F. Klis, J. Kurjan, H. Bussey i P. N. Lipke. "Glycosyl phosphatidylinositol-dependent cross-linking of alpha-agglutinin and beta 1,6-glucan in the Saccharomyces cerevisiae cell wall." Journal of Cell Biology 128, nr 3 (1.02.1995): 333–40. http://dx.doi.org/10.1083/jcb.128.3.333.
Pełny tekst źródłaGrabińska, Kariona A., Paula Magnelli i Phillips W. Robbins. "Prenylation of Saccharomyces cerevisiae Chs4p Affects Chitin Synthase III Activity and Chitin Chain Length". Eukaryotic Cell 6, nr 2 (1.12.2006): 328–36. http://dx.doi.org/10.1128/ec.00203-06.
Pełny tekst źródłaGross, Sascha, Sjoerd F. Bakker, Adriaan A. Van Bodegraven, Ingrid M. W. Van Hoogstraten, Kyra A. Gelderman, Gerd Bouma, Chris J. Mulder, B. Mary E. Von Blomberg i Hetty J. Bontkes. "Increased IgA Glycoprotein-2 Specic Antibody Titres in Refractory Celiac Disease". Journal of Gastrointestinal and Liver Diseases 23, nr 2 (1.06.2014): 127–33. http://dx.doi.org/10.15403/jgld.2014.1121.232.sg1.
Pełny tekst źródłaKurokawa, Tomoyo, Chunyeon Lee, Naofumi Shiomi, Atsushi Nakano i Shigeo Katoh. "Secretion of α-Amylase from Saccharomyces cerevisiae and Pichia pastoris and Characterization of Its C-Terminus with an Anti-Peptide Antibody". JOURNAL OF CHEMICAL ENGINEERING OF JAPAN 35, nr 12 (2002): 1277–81. http://dx.doi.org/10.1252/jcej.35.1277.
Pełny tekst źródłaYang, Huiying, Kent D. Taylor, Ying-Chao Lin, Stephan R. Targan i Jerome I. Rotter. "Magnitude of anti-saccharomyces cerevisiae antibody (ASCA) expression is linked, in crohn's disease, families to the major histocompatibility complex (MHC) region". Gastroenterology 118, nr 4 (kwiecień 2000): A339. http://dx.doi.org/10.1016/s0016-5085(00)83453-8.
Pełny tekst źródłaTaylor, KD, Z. Li, M. Barry, N. Fischel-Ghodsian, SE Plevy, JI Rotter, SR Targan i H. Yang. "Tumor necrosis factor microsatellite haplotype A11B4C1D3E3 is associated with anti-Saccharomyces cerevisiae antibody (ASCA) across clinical forms of inflammatory bowel disease". Gastroenterology 114 (kwiecień 1998): A1098. http://dx.doi.org/10.1016/s0016-5085(98)84463-6.
Pełny tekst źródłaVasseur, Francis, Boualem Sendid, Thierry Jouault, Annie Standaert-Vitse, Laurent Dubuquoy, Nadine Francois, Corinne Gower-Rousseau i in. "Variants of NOD1 and NOD2 genes display opposite associations with familial risk of crohnʼs disease and anti-saccharomyces cerevisiae antibody levels". Inflammatory Bowel Diseases 18, nr 3 (marzec 2012): 430–38. http://dx.doi.org/10.1002/ibd.21817.
Pełny tekst źródłaChen, Qingquan, Shirong Huang, Yue Wu, Shuyu Zhang, Qicai Liu i Min Chen. "Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease". Gastroenterology Research and Practice 2021 (4.08.2021): 1–6. http://dx.doi.org/10.1155/2021/4963641.
Pełny tekst źródłaKaila, Brinderjit, Kenneth Orr i Charles N. Bernstein. "The Anti-Saccharomyces Cerevisiae Antibody Assay in a Province-Wide Practice: Accurate in Identifying Cases of Crohn’s Disease and Predicting Inflammatory Disease". Canadian Journal of Gastroenterology 19, nr 12 (2005): 717–21. http://dx.doi.org/10.1155/2005/147681.
Pełny tekst źródłaKim, B. C., S. Park, J. Han, J. H. Kim, T. I. Kim i W. H. Kim. "Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course". Digestive and Liver Disease 39, nr 7 (lipiec 2007): 610–16. http://dx.doi.org/10.1016/j.dld.2007.03.006.
Pełny tekst źródłaLevendoglu, Hulya. "Idiopathic Ulcerations of the Esophagus (IUE) in HIV Infection with Positive Anti-Saccharomyces Cerevisiae Antibody (ASCA); Coincidence or Causation, a Case Report". American Journal of Gastroenterology 101 (wrzesień 2006): S325. http://dx.doi.org/10.14309/00000434-200609001-00807.
Pełny tekst źródłaKim, You Sun, Young-Ho Kim, Won Ho Kim, Joo Sung Kim, Young Sook Park, Suk-Kyun Yang, Byong Duk Ye i in. "Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis". Clinica Chimica Acta 412, nr 17-18 (sierpień 2011): 1527–32. http://dx.doi.org/10.1016/j.cca.2011.04.029.
Pełny tekst źródłaVojdani, Aristo. "Elevated IgG Antibody to Aluminum Bound to Human Serum Albumin in Patients with Crohn’s, Celiac and Alzheimer’s Disease". Toxics 9, nr 9 (4.09.2021): 212. http://dx.doi.org/10.3390/toxics9090212.
Pełny tekst źródłaGencheva, Marieta, Mitsuo Kato, Alain N. S. Newo i Ren-Jang Lin. "Contribution of DEAH-box protein DHX16 in human pre-mRNA splicing". Biochemical Journal 429, nr 1 (14.06.2010): 25–32. http://dx.doi.org/10.1042/bj20100266.
Pełny tekst źródłaDowhanick, T. M., S. W. Scherer, G. Willick, I. Russell, G. G. Stewart i V. L. Seligy. "Differential glucoamylase expression in Schwanniomyces castellii induced by maltose". Canadian Journal of Microbiology 34, nr 3 (1.03.1988): 262–70. http://dx.doi.org/10.1139/m88-048.
Pełny tekst źródłaSendid, Boualem, Nicolas Salvetat, Helène Sarter, Severine Loridant, Catherine Cunisse, Nadine François, Rachid Aijjou i in. "A Pilot Clinical Study on Post-Operative Recurrence Provides Biological Clues for a Role of Candida Yeasts and Fluconazole in Crohn’s Disease". Journal of Fungi 7, nr 5 (22.04.2021): 324. http://dx.doi.org/10.3390/jof7050324.
Pełny tekst źródła